Effect of Qurs-i-Shibb in Kathrat-i-Tamth (HMB): An observational clinical study.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Decrease in Bleeding
研究概览
简要总结
Title of study: Effect of Qurs-i-Shibb in Kathrat-i-TÌ£amth (HMB): An observational clinical study*.* Menorrhagia is a Greek word, derived from two words; men means menses and rrhagia means burst forth.It is generally defined as excessive bleeding, either in duration or quantity of blood loss or both (> 8 days and/or >80 ml) at regular intervals.In Unani system of medicine several single drugs such as bartang, tabasheer,shibbe yamani, khurfa, geru, sange jarahat, damul akhwain, rasaut and compound drugs are safoofe habis, majoone busd,qurse gulnar, qurse kahruba, sharbate injebar, Qurs-i-Shibb etc*.* are available to control heavy bleeding and are more convenient being administered and more over it is non-hormonal treatment. Among these drugs Qurs-i-Shibbis selected to evaluate its efficacy in the management of Kathrat-i-TÌ£amth. Procedure of the study:Diagnosed cases of Kathrat-i-TÌ£amth will be informed about the study procedures and written consent will be obtained. Orally Qurs-i-Shibb two tablets will be administrated thrice daily for 5 days from day 1 of cycle for 2 cycles. Follow up of patient will be done before and after each cycle for 2 consecutive cycles during trial and one follow up after completion of trial.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)(—)
- 性别
- Female
入选标准
- •1-Women between the ages of 18-40 Years.
- •2-Regular cycles with heavy bleeding in duration or amount of flow or both.
排除标准
- •Patients with 1-Hb less than 8.5 gm%.
- •2-H/o systemic diseases and blood dyscrasia.
- •3-H/o of pelvic pathology and malignancy.
- •4-H/o of OCPs,IUCD insertion in last 3 months.
结局指标
主要结局
Decrease in Bleeding
时间窗: One and half year
(amount/ duration)
时间窗: One and half year
次要结局
- Change in(1-PBAC Score(100))
